8-K Warning Letter


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported):  February 7, 2012
Merit Medical Systems, Inc.
(Exact name of registrant as specified in its charter)
Utah
 
0-18592
 
87-0447695
(State or other jurisdiction of
 
(Commission
 
(I.R.S. Employer
incorporation or organization)
 
File Number)
 
Identification No.)
 
1600 West Merit Parkway
 
 
South Jordan, Utah
 
84095
(Address of principal executive offices)
 
(Zip Code)
 
(801) 253-1600
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 




Item 7.01 Regulation FD Disclosure.
On February 7th, 2012, Merit Medical Systems, Inc., a Utah corporation, issued a press release addressing correspondence it received from the U.S. Food and Drug Administration. A copy of the press release is attached as Exhibit 99.1.
Item 9.01 Exhibits.

(d)    Exhibits

99.1 Press release, dated February 7, 2012, entitled: "Merit Medical Systems Receives FDA Warning Letter Regarding Merit Laureate® Hydrophilic Guidewire"

2



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MERIT MEDICAL SYSTEMS, INC.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Date: February 9, 2012
 
By:
 
/s/ Rashelle Perry
 
 
 
 
Chief Legal Officer
 
 


3



EXHIBIT INDEX
 
EXHIBIT
NUMBER
 
DESCRIPTION
 
 
 
99.1
 
Press Release, dated February 7, 2012, entitled "Merit Medical Systems Receives FDA Warning Letter Regarding Merit Laureate® Hydrophilic Guidewire."


4